Importantly, the main active component of TSE was found to be pentagalloyl glucose (3), which showed strong inhibition (IC50 = 2.79 μM) of XO and also lowered serum uric acid levels in rats with PO-induced hyperuricemia. Here, XDH is linked to hyperuricemia.